Showing results (611-620 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|January 5, 2010
Monoclonal antibodies in the treatment of pancreatic cancerZhi-Qiang Huang, Donald J BuchsbaumImmunotherapy|June 28, 2017
The future of immune checkpoint cancer therapy after PD-1 and CTLA-4Andrew W Hahn, David M Gill, Sumanta K Pal, et al.Immunotherapy|June 28, 2017
Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimenYonghao Yang, Hongwei Lin, Lingdi Zhao, et al.Immunotherapy|July 21, 2018
Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathwayDandan Wang, Song Bai, Yulin Cui, et al.Immunotherapy|August 6, 2020
Romosozumab in the treatment of osteoporosisAlexandra O Kobza, Alexandra Papaioannou, Arthur N Lau, et al.Immunotherapy|February 26, 2015
Progress in biosimilar monoclonal antibody development: the infliximab biosimilar CT-P13 in the treatment of rheumatic diseasesJürgen Braun, Alex KudrinImmunotherapy|February 26, 2015
Cytomegalovirus-specific T-cell therapies: current status and future prospectsEmma Nicholson, Karl S PeggsImmunotherapy|February 26, 2015
Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of grayNicky J C Woittiez, Bart O RoepImmunotherapy|May 4, 2023
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysisHui Liu, Chun-Cheng Yang, Yun-Long Ma, et al.Immunotherapy|April 4, 2023
Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer centerRebecca Jeun, Priyanka C Iyer, Conor Best, et al.Pageof 188